Article info
PDFEditors’ commentary
Highlights from this issue
- Correspondence to Dr Geraint N Fuller, Gloucester Royal Hospital, Gloucester GL1 3NN, UK; geraint.fuller{at}nhs.net
Citation
Highlights from this issue
Publication history
- Accepted February 18, 2021
- First published March 16, 2021.
Online issue publication
March 16, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Camptocormia in Parkinson 's disease: definition, epidemiology, pathogenesis and treatment modalities
- Parkinson ’s disease with camptocormia
- Subthalamic nucleus stimulation improves Parkinson 's disease - associated camptocormia in parallel to its preoperative levodopa responsiveness
- A practical approach to the patient presenting with dropped head
- Head drop and camptocormia
- Camptocormia in Parkinson disease: an epidemiological and clinical study
- Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit
- Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study
- Seizures and movement disorders: phenomenology, diagnostic challenges and therapeutic approaches
- A specific clinical pattern of camptocormia in Parkinson ’s disease